Y. Kumagai et al., INHIBITION OF NITRIC-OXIDE FORMATION BY NEURONAL NITRIC-OXIDE SYNTHASE BY QUINONES - NITRIC-OXIDE SYNTHASE AS A QUINONE REDUCTASE, Chemical research in toxicology, 11(6), 1998, pp. 608-613
Inhibitory action of a variety of quinoid compounds on neuronal nitric
oxide synthase (nNOS) activity was examined with a 20000g rat cerebel
lar supernatant preparation and purified nNOS. The inhibition of citru
lline formation from L-arginine by quinones, which exhibit one-electro
n reduction potentials (E-7(1)) ranging between -240 and -100 mV, incr
eased at a more positive one-electron reduction potential, suggesting
that quinone appears to act as an electron acceptor for nNOS. Among th
e quinones tested, 9,10-phenanthraquinone (PQ), corresponding to an E-
7(1) value of -124 mV, exhibited the most potent inhibiton of citrulli
ne formation (IC50 value = 10 mu M). A kinetic study revealed that PQ
is a competitive inhibitor with respect to NADPH, with a K-i value of
0.38 +/- 0.12 mu M, and a noncompetitive inhibitor with respect to L-a
rginine, with a K-i value of 9.63 +/- 0.20 mu M. Partial purification
of the enzymes which are responsible for reducing PQ in 20000g superna
tant of rat cerebellum by anion-exchange column chromatography indicat
ed that one catalyst for PQ reduction was nNOS. Reductase activity of
PQ by purified nNOS required CaCl2/calmodulin and was markedly suppres
sed by the flavoprotein inhibitor diphenyleneiodonium but not by L-nit
roarginine which is a specific inhibitor for NO formation. nNOS effect
ively reduced the quinones as well as PQ causing a marked decrease in
the production of NO from L-arginine, while 1,4-benzoquinone, 9,10-ant
hraquinone, mitomycin C, and lapachol, which show negligible inhibitor
y action on nNOS activity, were poor substrates for the enzyme on redu
ction. These results indicate that PQ and other quinones used in the p
resent study interact with the NADPH-cytochrome P450 reductase domain
on nNOS and thus probably inhibit NO formation by shunting electrons a
way from the normal catalytic pathway. Therefore, our study suggests t
hat quinones could possibly affect NO-dependent physiological and/or p
athophysiological actions in vivo.